Takayuki Yoshino
President of the Japanese Society of Medical Oncology and a leading gastrointestinal oncologist known for the PARADIGM trial and Asia-Pacific precision-oncology screening programmes.
Overview
Takayuki Yoshino is President of the Japanese Society of Medical Oncology (JSMO) and Professor at Keio University School of Medicine's Global Center of Research Excellence on Advanced Medicine. He is a gastrointestinal medical oncologist who led the PARADIGM randomised trial of panitumumab versus bevacizumab in RAS wild-type left-sided metastatic colorectal cancer. He has also driven large genomic screening platforms for GI cancers in Japan and the Asia-Pacific region.
Pages like this
not linked directly; found by shared links- PersonHidetoshi Hayashi
Shares Japanese Society of Medical Oncology and the tags leadership, clinician-scientist.
- PersonFlorian R. Greten
Shares Gastric & gastro-oesophageal junction cancer, Colorectal cancer and the tags leadership, clinician-scientist, colorectal cancer.
- PersonChee Cheng Ean
Shares Gastric & gastro-oesophageal junction cancer, Colorectal cancer and the tags leadership, clinician-scientist.
- PersonGeerard Beets
Shares Colorectal cancer and the tags leadership, clinician-scientist, colorectal cancer.
- PersonTheodore R. Levin
Shares Colorectal cancer and the tags leadership, clinician-scientist, colorectal cancer.
- PersonOwen Sansom
Shares Colorectal cancer and the tags leadership, clinician-scientist, colorectal cancer.
- PersonIgor Kiss
Shares Colorectal cancer and the tags leadership, clinician-scientist, colorectal cancer.
- PersonJanja Ocvirk
Shares Colorectal cancer and the tags leadership, clinician-scientist, colorectal cancer.